Park Medi World Share Price
285.20-1.50 (-0.52%)
+92.77% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 9% | 13% |
| - | - | 4% | 40% |
| - | - | - | - |
| 32% | 32% | 28% | 22% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
PARKHOSPS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,655.5 | ₹126300 Cr | 60.45 | 40.39 | 207.67 | ₹1942 Cr |
| 987.9 | ₹96763 Cr | 66.42 | 3.31 | 19.84 | ₹1442 Cr |
| 728.95 | ₹95496 Cr | 107.02 | 1.96 | 11.95 | ₹892 Cr |
| 905.8 | ₹68901 Cr | 65.75 | 3.53 | 20.1 | ₹1042 Cr |
| 786.65 | ₹68592 Cr | 215.24 | 0.31 | 6.76 | ₹464 Cr |
| 1,860 | ₹38439 Cr | 47.1 | 10.14 | 65.36 | ₹806 Cr |
| 1,470.8 | ₹38149 Cr | 68.59 | 5.91 | 29.85 | ₹556 Cr |
| 1,877.1 | ₹32259 Cr | 59.53 | 10.11 | 42.51 | ₹505 Cr |
| 764.8 | ₹32231 Cr | 157.77 | 1.04 | 12.74 | ₹241 Cr |
| 513.85 | ₹16249 Cr | 109.52 | 1.43 | 13.88 | ₹133 Cr |
| 285.2 | ₹12388 Cr | 47.99 | 1.91 | 7.42 | ₹274 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ₹476 Cr | ₹460 Cr | ₹410 Cr | ₹399 Cr | ₹354 Cr | ₹348 Cr |
| ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹7 Cr | ₹9 Cr | ₹15 Cr |
| ₹483 Cr | ₹468 Cr | ₹419 Cr | ₹406 Cr | ₹362 Cr | ₹363 Cr |
| ₹368 Cr | ₹351 Cr | ₹326 Cr | ₹309 Cr | ₹281 Cr | ₹280 Cr |
| ₹134 Cr | ₹135 Cr | ₹109 Cr | ₹112 Cr | ₹97 Cr | ₹98 Cr |
| ₹10 Cr | ₹14 Cr | ₹15 Cr | ₹15 Cr | ₹16 Cr | ₹16 Cr |
| ₹105 Cr | ₹103 Cr | ₹78 Cr | ₹82 Cr | ₹66 Cr | ₹67 Cr |
| ₹89 Cr | ₹77 Cr | ₹53 Cr | ₹66 Cr | ₹52 Cr | ₹46 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹77 Cr | ₹77 Cr | ₹77 Cr | ₹77 Cr |
| ₹993 Cr | ₹806 Cr | ₹610 Cr | ₹380 Cr |
| ₹981 Cr | ₹794 Cr | ₹598 Cr | ₹368 Cr |
| ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| ₹1070 Cr | ₹883 Cr | ₹687 Cr | ₹457 Cr |
| ₹57 Cr | ₹53 Cr | ₹43 Cr | ₹87 Cr |
| ₹384 Cr | ₹391 Cr | ₹318 Cr | ₹371 Cr |
| ₹0 | ₹0 | ₹83 L | ₹83 L |
| -₹12 Cr | -₹6 Cr | ₹49 L | ₹7 Cr |
| ₹56 Cr | ₹51 Cr | ₹17 Cr | ₹13 Cr |
| ₹11 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr |
| ₹440 Cr | ₹444 Cr | ₹341 Cr | ₹396 Cr |
| — | — | — | — |
| ₹136 Cr | ₹90 Cr | ₹60 Cr | ₹44 Cr |
| ₹175 Cr | ₹175 Cr | ₹158 Cr | ₹117 Cr |
| ₹164 Cr | ₹159 Cr | ₹155 Cr | ₹76 Cr |
| ₹81 Cr | ₹102 Cr | ₹149 Cr | ₹116 Cr |
| ₹556 Cr | ₹527 Cr | ₹521 Cr | ₹353 Cr |
| ₹2122 Cr | ₹1906 Cr | ₹1593 Cr | ₹1293 Cr |
| ₹751 Cr | ₹734 Cr | ₹602 Cr | ₹592 Cr |
| ₹622 Cr | ₹633 Cr | ₹557 Cr | ₹503 Cr |
| — | — | — | — |
| ₹1110 Cr | ₹1003 Cr | ₹606 Cr | ₹492 Cr |
| ₹212 Cr | ₹166 Cr | ₹70 Cr | ₹34 Cr |
| ₹898 Cr | ₹837 Cr | ₹536 Cr | ₹458 Cr |
| ₹37 Cr | ₹32 Cr | ₹5 Cr | ₹29 Cr |
| ₹9 L | ₹9 L | ₹0 | ₹0 |
| ₹9 L | ₹9 L | ₹0 | ₹0 |
| ₹94 Cr | ₹75 Cr | ₹83 Cr | ₹31 Cr |
| ₹60 Cr | ₹18 Cr | ₹108 Cr | ₹51 Cr |
| ₹1088 Cr | ₹963 Cr | ₹731 Cr | ₹570 Cr |
| — | — | — | — |
| ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr |
| ₹614 Cr | ₹511 Cr | ₹576 Cr | ₹449 Cr |
| ₹361 Cr | ₹390 Cr | ₹203 Cr | ₹192 Cr |
| ₹22 Cr | ₹14 Cr | ₹4 Cr | ₹8 Cr |
| ₹35 Cr | ₹26 Cr | ₹77 Cr | ₹68 Cr |
| ₹1034 Cr | ₹943 Cr | ₹862 Cr | ₹724 Cr |
| ₹478 Cr | ₹416 Cr | ₹340 Cr | ₹371 Cr |
| ₹2122 Cr | ₹1906 Cr | ₹1593 Cr | ₹1293 Cr |
| ₹28 | ₹57 | ₹44 | ₹29 |
| ₹28 | ₹23 | ₹18 | ₹12 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ₹287 Cr | ₹218 Cr | ₹315 Cr | ₹278 Cr |
| ₹102 Cr | ₹139 Cr | ₹101 Cr | ₹124 Cr |
| -₹113 Cr | ₹105 Cr | -₹118 Cr | -₹153 Cr |
| ₹276 Cr | ₹462 Cr | ₹299 Cr | ₹250 Cr |
| ₹191 Cr | ₹361 Cr | ₹199 Cr | ₹155 Cr |
| -₹91 Cr | -₹255 Cr | -₹234 Cr | -₹248 Cr |
| -₹74 Cr | -₹130 Cr | ₹1 Cr | ₹163 Cr |
| ₹26 Cr | -₹23 Cr | -₹34 Cr | ₹70 Cr |
| ₹77 Cr | ₹100 Cr | ₹151 Cr | ₹81 Cr |
| ₹103 Cr | ₹77 Cr | ₹117 Cr | ₹151 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found